Literature DB >> 12433321

Clostridium difficile-associated Enteric Disease.

John G. Bartlett1.   

Abstract

Clostridium difficile was identified as the putative agent of antibiotic-associated pseudomembranous colitis in 1978 and is now recognized as the major identifiable cause of antibiotic-associated diarrhea. This microbe causes a spectrum of enteric disease ranging from nuisance diarrhea to life-threatening colitis. Risk factors include increasing age, exposure to antibiotics, colonization or acquisition of toxin-producing strains of C. difficile, and lack of circulating antibody to C. difficile toxin A. Detection is relatively simple by stool assay for C. difficile toxin--usually an enzyme immunoassay that will detect toxin A and B. Most nonsevere cases will respond with discontinuation of the implicated antibiotic. More severe cases require metronidazole and supportive care. The major complications include ileus, toxic megacolon, relapsing disease after antibiotic treatment, and nosocomial epidemics.

Entities:  

Year:  2002        PMID: 12433321     DOI: 10.1007/s11908-002-0032-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.663


  44 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

2.  Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study.

Authors:  J Wiström; S R Norrby; E B Myhre; S Eriksson; G Granström; L Lagergren; G Englund; C E Nord; B Svenungsson
Journal:  J Antimicrob Chemother       Date:  2001-01       Impact factor: 5.790

3.  Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals.

Authors:  S Johnson; M H Samore; K A Farrow; G E Killgore; F C Tenover; D Lyras; J I Rood; P DeGirolami; A L Baltch; M E Rafferty; S M Pear; D N Gerding
Journal:  N Engl J Med       Date:  1999-11-25       Impact factor: 91.245

4.  A nosocomial outbreak of fluoroquinolone-resistant salmonella infection.

Authors:  S J Olsen; E E DeBess; T E McGivern; N Marano; T Eby; S Mauvais; V K Balan; G Zirnstein; P R Cieslak; F J Angulo
Journal:  N Engl J Med       Date:  2001-05-24       Impact factor: 91.245

5.  The effect of faecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhoea.

Authors:  A Gustafsson; A Berstad; S Lund-Tønnesen; T Midtvedt; E Norin
Journal:  Scand J Gastroenterol       Date:  1999-06       Impact factor: 2.423

6.  Staphylococcal enterocolitis--treatment with oral vancomycin.

Authors:  M Y Khan; W H Hall
Journal:  Ann Intern Med       Date:  1966-07       Impact factor: 25.391

7.  Reassessment of Clostridium difficile susceptibility to metronidazole and vancomycin.

Authors:  T Peláez; L Alcalá; R Alonso; M Rodríguez-Créixems; J M García-Lechuz; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 8.  The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida.

Authors:  Nasia Safdar; Dennis G Maki
Journal:  Ann Intern Med       Date:  2002-06-04       Impact factor: 25.391

9.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease.

Authors:  L V McFarland; C M Surawicz; R N Greenberg; R Fekety; G W Elmer; K A Moyer; S A Melcher; K E Bowen; J L Cox; Z Noorani
Journal:  JAMA       Date:  1994 Jun 22-29       Impact factor: 56.272

10.  Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal faeces.

Authors:  A Schwan; S Sjölin; U Trottestam; B Aronsson
Journal:  Scand J Infect Dis       Date:  1984
View more
  12 in total

1.  Importance of Molecular Methods to Determine Whether a Probiotic is the Source of Lactobacillus Bacteremia.

Authors:  Alla Aroutcheva; Julie Auclair; Martin Frappier; Mathieu Millette; Karen Lolans; Danielle de Montigny; Serge Carrière; Stephen Sokalski; William E Trick; Robert A Weinstein
Journal:  Probiotics Antimicrob Proteins       Date:  2016-03       Impact factor: 4.609

2.  An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo.

Authors:  Scott M Baliban; Amanda Michael; Berje Shammassian; Shikata Mudakha; Amir S Khan; Simon Cocklin; Isaac Zentner; Brian P Latimer; Laurent Bouillaut; Meredith Hunter; Preston Marx; Niranjan Y Sardesai; Seth L Welles; Jeffrey M Jacobson; David B Weiner; Michele A Kutzler
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

3.  Phylogeny-corrected identification of microbial gene families relevant to human gut colonization.

Authors:  Patrick H Bradley; Stephen Nayfach; Katherine S Pollard
Journal:  PLoS Comput Biol       Date:  2018-08-09       Impact factor: 4.475

4.  Clostridium difficile colonization in early infancy is accompanied by changes in intestinal microbiota composition.

Authors:  Clotilde Rousseau; Florence Levenez; Charlène Fouqueray; Joël Doré; Anne Collignon; Patricia Lepage
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

5.  Human intestinal microbiota gene risk factors for antibiotic-associated diarrhea: perspectives for prevention. Risk factors for antibiotic-associated diarrhea.

Authors:  Marie-France de La Cochetière; Emmanuel Montassier; Jean-Benoit Hardouin; Thomas Carton; Françoise Le Vacon; Tony Durand; Valerie Lalande; Jean Claude Petit; Gilles Potel; Laurent Beaugerie
Journal:  Microb Ecol       Date:  2010-02-26       Impact factor: 4.552

6.  Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.

Authors:  Patrizia Spigaglia; Fabrizio Barbanti; Anna Maria Dionisi; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

7.  Intestinal alkaline phosphatase prevents antibiotic-induced susceptibility to enteric pathogens.

Authors:  Sayeda Nasrin Alam; Halim Yammine; Omeed Moaven; Rizwan Ahmed; Angela K Moss; Brishti Biswas; Nur Muhammad; Rakesh Biswas; Atri Raychowdhury; Kanakaraju Kaliannan; Sathi Ghosh; Madhury Ray; Sulaiman R Hamarneh; Soumik Barua; Nondita S Malo; Atul K Bhan; Madhu S Malo; Richard A Hodin
Journal:  Ann Surg       Date:  2014-04       Impact factor: 12.969

Review 8.  Epidemiology and management of diverticular disease of the colon.

Authors:  Jin-Yong Kang; David Melville; J Douglas Maxwell
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis.

Authors:  Eran Elinav; David Planer; Moshe E Gatt
Journal:  Int J Colorectal Dis       Date:  2003-11-15       Impact factor: 2.571

10.  Antimicrobial susceptibility of clostridium difficile clinical isolates in iran.

Authors:  Mehdi Goudarzi; Hossein Goudarzi; Masoud Alebouyeh; Masoumeh Azimi Rad; Farahnaz Sadat Shayegan Mehr; Mohammad Reza Zali; Mohammad Mehdi Aslani
Journal:  Iran Red Crescent Med J       Date:  2013-08-05       Impact factor: 0.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.